Loading...

CRITICAL CARE ANTIBIOTICS FOR DRUG RESISTANT GRAM NEGATIVE BACTERIA / CULTURE

image not found

NABL Cap Accredited 
The Critical Care Antibiotics Panel for Drug-Resistant Gram-Negative Bacteria at Metropolis Healthcare is a culture-based test designed to identify effective antibiotics against resistant gram-negative infections. It guides targeted therapy in critically ill patients, reducing the risk of treatment failure. Metropolis ensures accurate results using advanced microbiology techniques and expert interpretation.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 1,200.00

Sample Type: CULTURE

Fasting Not Requierd


Frequently Asked Questions (FAQ's):

What is the Critical Care Antibiotics Panel?
It is a culture-based test at Metropolis Healthcare that identifies effective antibiotics for drug-resistant gram-negative bacterial infections.

Who should consider this test?
Critically ill patients, ICU patients, or those with persistent infections not responding to standard antibiotics may benefit.

What sample is required for this test?
Clinical specimens, such as blood, urine, or wound swabs, are collected for culture and sensitivity analysis at Metropolis Healthcare.

Is fasting required for this test?
No fasting is needed. The test can be performed without any special preparation.

How accurate are the results at Metropolis Healthcare?
Metropolis ensures high accuracy using validated culture methods, advanced antibiotic susceptibility testing, and expert microbiologists.

Can this test guide antibiotic therapy?
Yes, it identifies the most effective antibiotics to treat drug-resistant infections, optimizing therapy and patient outcomes.

How long does it take to get the results?
Results are typically available within 24–72 hours, depending on bacterial growth and sensitivity analysis.

How does this test help in managing infections?
It allows targeted treatment, prevents misuse of broad-spectrum antibiotics, reduces resistance risk, and improves recovery in critically ill patients.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab